Keywords
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'explorations sur les aspects psychologiques du Covid - Exploration (Accueil)

Index « Keywords » - entrée « Antiviral Agents (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antiviral Agents (administration & dosage) < Antiviral Agents (adverse effects) < Antiviral Agents (classification)  Facettes :

List of bibliographic references indexed by Antiviral Agents (adverse effects)

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000039 (2020) Markus Svensson[Potential harms associated with 4-aminoquinoline treatment].
000045 (2020) H. Javelot [France] ; P-M Llorca [France] ; D. Drapier [France] ; E. Fakra [France] ; C. Hingray [France] ; G. Meyer [France] ; S. Dizet [France] ; A. Egron [France] ; C. Straczek [France] ; M. Roser [France] ; M. Masson [France] ; R. Gaillard [France] ; P. Fossati [France] ; E. Haffen [France][Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
000056 (2020) H. Javelot [France] ; P-M Llorca [France] ; G. Meyer [France] ; P. Fossati [France] ; E. Haffen [France][Challenges for psychotropics in the context of the SARS-Cov-2 pandemic].
000107 (2020) Kai Zhang [République populaire de Chine] ; Xiaoqin Zhou [République populaire de Chine] ; Huanzhong Liu [République populaire de Chine] ; Kenji Hashimoto [Japon]Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders.
000343 (2020) Zeeshan Mansuri [États-Unis] ; Bhumika Shah ; Mahwish Adnan ; Gaurav Chaudhari ; Taranjeet JollyRitonavir/Lopinavir and Its Potential Interactions With Psychiatric Medications: A COVID-19 Perspective.
000A27 (2020) Antonio Cuadrado-Lavín [Espagne] ; José Manuel Olmos [Espagne] ; José Manuel Cifrian [Espagne] ; Teresa Gimenez [Espagne] ; Marco Antonio Gandarillas [Espagne] ; Mar García-Saiz [Espagne] ; Maria Henar Rebollo [Espagne] ; Victor Martínez-Taboada [Espagne] ; Marcos L Pez-Hoyos [Espagne] ; María Carmen Fari As [Espagne] ; Javier Crespo [Espagne]Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidPsychoV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antiviral Agents (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antiviral Agents (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidPsychoV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiviral Agents (adverse effects)
}}
Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Fri Jul 31 19:14:22 2020. Site generation: Thu Mar 25 19:13:26 2021